Related Experiment Video
Updated: May 23, 2026

Characteristics of Precipitation-formed Polyethylene Glycol Microgels Are Controlled by Molecular Weight of Reactants
Published on: December 23, 2013
Use of polyethylene glycol in children less than 3 years of age
Mansoor Ahmed1, Bharathi Pai, Tim Reynolds
1Department of Paediatrics, Burton Hospitals NHS Foundation Trust, Queen's Hospital, Staffordshire, United Kingdom. mansoor.ahmed@burtonft.nhs.uk
Insights
Polyethylene glycol (PEG) effectively treats chronic constipation in young children, significantly increasing stool frequency. Further research is needed to confirm its safety and efficacy in infants.
Area of Science:
- Pediatric Gastroenterology
- Pharmacology
Background:
- Chronic constipation is a prevalent gastrointestinal issue in pediatric populations.
- Polyethylene glycol (PEG) is an established treatment for constipation in older children.
Purpose of the Study:
- To evaluate the efficacy and safety of polyethylene glycol (PEG) in infants and children under three years of age.
- To review existing literature on PEG use in this specific age group.
Main Methods:
- A comprehensive literature review was conducted using Medline, Cinahl, and Embase databases.
- Searched databases for studies published between 1950 and 2010.
- Included only studies focusing on children under three years old.
Main Results:
- Only five relevant studies were identified for children under three years old.
- Pooled analysis demonstrated a statistically significant improvement in stool frequency post-PEG treatment (p < 0.001).
Conclusions:
- Limited evidence currently supports the use of PEG for safety and efficacy in young children.
- Larger, randomized controlled trials are essential, particularly for infants, to substantiate these findings.
Abstract:
Chronic constipation is extremely common gastrointestinal problem in children. Polyethylene glycol (PEG) has been shown to be effective for both disimpaction and maintenance treatment in older children with chronic constipation. Literature review was carried out using Medline via PubMed (1950 to 2010), Cinahl (1982 - 2010) and Embase (1974 to 2010) to evaluate the efficacy and safety of PEG in infants and children less than 3 years of age. There were no relevant reviews in the Cochrane Library. Only 5 relevant studies were found for children in the age group below 3 years. Pooled analysis of all the studies showed a statistically significant difference in the stool frequency before and after treatment with polyethylene glycol (p < 0.001). Although, limited published evidence to date supports its use in terms of safety and efficacy, larger randomized controlled trials are needed especially in young infants to substantiate the evidence.
More Related Videos
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
15:33Microwave-assisted Functionalization of Poly(ethylene glycol) and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation
Published on: October 29, 2013
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Prevention of Further Absorption of Poison